Neurogenic vasoconstriction as affected by cholinergic and nitroxidergic nerves in dog ciliary and ophthalmic arteries

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 8, 1999, Pages 1753-1760

  Toda, Megumi ^a   Okamura, Tomio ^a   Ayajiki, Kazuhide ^a   Toda, Noboru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CHOLINERGIC NERVE; CILIARY ARTERY; CONTROLLED STUDY; DOG; ELECTROSTIMULATION; NERVE ENDING; NERVE FUNCTION; NERVE STIMULATION; NONHUMAN; OPHTHALMIC ARTERY; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC FIBERS; CILIARY ARTERIES; DOGS; ELECTRIC STIMULATION; FEMALE; ISOMETRIC CONTRACTION; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROARGININE; NOREPINEPHRINE; OPHTHALMIC ARTERY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, PURINERGIC P2; VASOCONSTRICTION;

EID: 0032989629     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Harris A, Sergott RC, Spaeth GL, Katz JL, Shoemaker JA, Martin BJ. Color doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol. 1994;118:642-649.
2. Nicolela MY, Drance SM, Rankin SJA, Buckley AR, Walman BE. Color doppler imaging in patients with asymmetric glaucoma and bilateral visual field loss. Am J Ophthalmol. 1996;121:502-510.
3. Stone RA, Kuwayama Y. The nervous system and intraocular pressure. In: Ritch R, Shields MB, Krupin T, eds. The Glaucoma. St. Louis: Mosby; 1989:257-279.
4. Morris JL, Gibbins IL, Kadowitz PJ, et al. Roles of peptides and other substances in cotransmission from vascular autonomic and sensory neurons. Can J Physiol Pharmacol. 1995;73:521-532.
5. Flavahan NA, Vanhoutte PM. Sympathetic purinergic vasoconstriction and thermosensitivity in a canine cutaneous vein. J Pharmacol Exp Ther. 1986;239:784-789.
6. Granstam E, Nilsson FE. Non-adrenergic sympathetic vasoconstriction in the eye and some other facial tissues in the rabbit. Eur J Pharmacol. 1990;175:175-186.
7. Toda N, Okamura T. Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarterial muscle. Biochem Biophys Res Commun. 1990;170:308-313.
8. Toda N, Okamura T. Nitroxidergic nerve: regulation of vascular tone and blood flow in the brain. J Hypertens. 1996;14:423-434.
9. Nilsson SFE, Bill A. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flow. Acta Physiol Scand. 1984; 121:385-392.
10. 2-purinoceptors in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol. 1985;111:49-56.
11. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial muscle by acetylcholine. Nature. 1980; 288:373-376.
12. Zhang JX, Okamura T, Toda N. Prejunctional regulation by endogenous and exogenous acetylcholine of adrenergic nerve function in isolated canine mesenteric arteries. Hypertens Res. 1997;20: 119-125.
13. Toda N, Kitamura Y, Okamura T. Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Physiol. 1994;266:H1985-H1992.
14. Toda N, Kitamura Y, Okamura T. Functional role of nerve-derived nitric oxide in isolated dog ophthalmic arteries. Invest Ophthalmol Vis Sci. 1995;36:563-570.
15. Toda N, Toda M, Ayajiki K, Okamura T. Monkey central retinal artery is innervated by nitroxidergic vasodilator nerves. Invest Ophthalmol Vis Sci. 1996;37:2177-2184.
16. Toda M, Okamura T, Azuma I, Toda N. Modulation by neurogenic acetylcholine of nitroxidergic nerve function in porcine ciliary arteries. Invest Ophthalmol Vis Sci. 1997;38:2261-2269.
17. 2-purinoceptor? Gen Pharmacol. 1985;16:433-440.
18. Daly JW. Adenosine receptors: target sites for drugs. J Med Chem. 1982;25:197-207.
19. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylate cyclase by 1H-[1,2,4]oxadiazolo[4,4-a]quinoxalin-1-one. Mol Pharmacol. 1995;48:184-188.
20. 2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988;93: 243-245.
21. 1 receptor antagonist: BIBP3226. Eur J Pharmacol. 1994;271:R11-R13.
22. G-nitro-L-arginine on the contraction of the dog temporal artery elicited by transmural stimulation of noradrenergic nerves. Naunyn Schmiedebergs Arch Pharmacol. 1991;343:221-224.
23. Toda N, Okamura T. Regulation by nitroxidergic nerve to arterial tone. News Physiol Sci. 1992;7:148-152.
24. Dawson TM, Bredt DS, Fotuhi, M, Hwang PM, Snyder SH. Nitricoxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA. 1991;88: 7797-7801.
25. 2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol. 1995;35:541-579.
26. Stone RA, Kuwayama Y, Laties AM. Regulatory peptides in the eye. Experientia. 1987;43:791-800.
27. Malmstrom RE, Lundberg JM. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435. Eur J Pharmacol. 1995;294:661-668.
28. Toda N, Ayajiki K. Cholinergic prejunctional inhibition of vasodilator nerve function in bovine basilar arteries. Am J Physiol. 1990; 258:H983-H986.
29. Laties AM, Jacobowitz D. A comparative study of the autonomic innervation of the eye in monkey, cat and rabbit. Anat Rec. 1966; 156:383-396.
30. Duckies SP, Kennedy CD. Cerebral blood vessels: effects of exogenous acetylcholine and field stimulation on norepinephrine release. J Pharmacol Exp Ther. 1982;222:562-565.
31. Rorie DK, Rusch NJ, Shepherd JT, Vanhoutte PM, Tyce GM. Prejunctional inhibition of norepinephrine release caused by acetylcholine in the human saphenous vein. Circ Res. 1981;49:337-341.
32. Toda N, Inoue H, Okamura T. Intra- and extraluminally-applied acetylcholine on the vascular tone or the response to transmural stimulation in dog isolated mesenteric arteries. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:30-36.
33. Wiencke AK, Nilsson H, Nielssen PJ, Nyborg NCB. Nonadrenergic noncholinergic vasodilation in bovine ciliary artery involves CGRP and neurogenic nitric oxide. Invest Ophthalmol Vis Sci. 1994;35: 3268-3277.
34. Nyborg NCB, Nielssen PJ. Neurogenic nitric oxide accounts for the non-adrenergic non-cholinergic vasodilation in human ciliary arteries [ARVO Abstract). Invest Ophthalmol Vis Sci. 1994;35(4): S1287. Abstract nr 158-2.
35. Williams M. Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol. 1987; 27:315-345.
36. Gruetter CA, Kadowitz PJ, Ignarro LJ. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol. 1982;59:150-156.
37. O'Rourke ST, Vanhoutte PM. Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein. J Pharmacol Exp Ther. 1987;241:64-67.
38. 3 receptors in cat cerebral arteries. Brain Res. 1991;567:76-82.
39. Toda N, Ayajiki K, Okamura T. Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries. J Physiol. 1997;498:453-461.